arrow
M

Matthias Eder

University of Freiburg
H指数:65
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Complications of Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide—A Prospective Study on Behalf of the EBMT Transplant Complications Working Party

haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide的并发症——EBMT移植并发症工作组发起的一项前瞻性研究

2025-12-180
OAAI
First-in-Human PET Imaging of MT1-MMP in a Patient with Breast and Muscle-Invasive Urothelial Bladder Cancer Using the Bicyclic Radiotracer [68Ga]Ga-BCY25286

使用双环放射性示踪剂[68Ga]Ga-BCY25286对一名患有乳腺癌和肌肉浸润性尿路上皮膀胱癌的患者进行MT1-MMP首次人体PET成像

2025-12-010
PRE
TET2 mutation does not impact the prognosis of adult acute myeloid leukemia patients receiving a hematopoietic stem cell transplantation in first remission: similar outcome following matched sibling and unrelated versus haploidentical donor transplants in amulti-center retrospective analysis from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

TET2突变不影响接受造血干细胞移植且处于首次缓解期的成人急性髓系白血病患者的预后:欧洲血液与骨髓移植学会全球委员会和急性白血病工作组的多中心回顾性分析显示,配型相合的同胞或无关供者移植与单倍型相合供者移植后的结果相似。

2025-12-010
OAAI
Impact of donor selection in adverse-risk AML undergoing hematopoietic cell transplantation: A study from the EBMT Acute Leukemia Working Party

供者选择对不良风险AML接受造血细胞移植的影响:EBMT急性白血病工作组的研究

2025-11-290
PRE
Performance of treatment response assessment at day 7 by baseline acute graft-vs-host disease severity

基于基线急性移植物抗宿主病严重程度的第7天治疗反应评估表现

2025-09-250
PRE
Allogeneic hematopoietic cell transplantation for older patients with Philadelphia-positive acute lymphoblastic leukemia. A study by the Acute Leukemia Working Party of the EBMT

异基因造血细胞移植治疗费城染色体阳性急性淋巴细胞白血病的老年患者。EBMT急性白血病工作组的研究。

2025-07-160
PRE
Challenging the Adverse Label: Diverse Outcomes of ELN 2022 Adverse Cytogenetic Subgroups in Acute Myeloid Leukemia Patients Allografted in First Remission: From EBMT ALWP

挑战不良标签:急性髓系白血病患者在首次缓解期进行同种异体移植的ELN 2022不良细胞遗传学亚组的多样化结局:来自EBMT ALWP

2025-05-300
PRE
Methotrexate Versus Mycophenolate Mofetil Prophylaxis in Allogeneic Hematopoietic Cell Transplantation for Chronic Myeloid Malignancies: A Retrospective Analysis on Behalf of the Chronic Malignancies Working Party of the EBMT
2024-11-280
PRE
Prognostic Impact of Subclinical FLT3-ITD Microclones in Patients with Acute Myeloid Leukemia

亚临床FLT3-ITD微克隆对急性髓系白血病患者预后的影响

BLOOD
IF23.1
2024-11-050
PRE
Challenging the Adverse Label: Diverse Outcomes of ELN 2022 Adverse Cytogenetic Subgroups in Acute Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation in First Remission: On Behalf of the EBMT Acute Leukemia Working Party

挑战不良标签:急性髓系白血病患者在首次缓解期接受 allo-HCT 时,ELN 2022 不良细胞遗传学亚组的不同结局:代表 EBMT 急性白血病工作组。

BLOOD
IF23.1
2024-11-050
PRE
Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients

黑人和白人患者急性移植物抗宿主病 (GVHD) 严重程度及其结局的差异

2024-11-011
PRE
Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis
2024-04-233
OAAI
A Day 14 Endpoint for Acute GVHD Clinical Trials
2024-04-012
OAAI
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry
LEUKEMIA
IF13.4
2024-03-284
OAAI